OpenURL Connection Search

Select item for more details and to access through your institution.

Antigenicity and immunogenicity of a novel, acute HIV-1 Tanzanian subtype C gp145 envelope protein for clinical development.
Published in:
2012
By:
- Polonis, V.;
- Wieczorek, L.;
- Kalyanaraman, V.;
- Matyas, G.;
- Whitney, S.;
- Williams, C.;
- Tovanabutra, S.;
- Sanders-Buell, E.;
- Wesberry, M.;
- Ochsenbauer, C.;
- Chenine, A.;
- Rao, M.;
- Tong, T.;
- Alving, C.;
- Cheng, H.;
- Zolla-Pazner, S.;
- Michael, N.;
- VanCott, T.;
- Marovich, M.
Publication type:
Abstract
Immunogenic selection of HIV-1 MPER epitopes for improved vaccine design.
Published in:
2012
By:
- Wieczorek, L.;
- Rao, M.;
- Peachman, K.;
- Steers, N.;
- Marovich, M.;
- Michael, N.;
- Polonis, V.;
- Rao, V.
Publication type:
Abstract
The impact of differences in viral entry and trafficking on the mechanism of HIV-1 neutralization.
Published in:
2012
By:
- Macedo Cincotta, C. D.;
- Wieczorek, L. M.;
- Barrows, B.;
- Brown, B.;
- Asher, L.;
- Michael, N.;
- Marovich, M.;
- Polonis, V. R.
Publication type:
Abstract
Neutralization and enhancement of trans infection by erythrocyte-bound HIV with antibodies and complement.
Published in:
2012
By:
- Beck, Z.;
- Matyas, G. R.;
- Polonis, V. R.;
- Alving, C. R.
Publication type:
Abstract
Passive immunization with polyclonal anti-SHIV IgG: partial protection or increased acquisition of heterologous tier 2 SHIV - depending on IgG dose.
Published in:
2012
By:
- Sholukh, A. M.;
- Siddappa, N. B.;
- Shanmuganathan, V.;
- Lakhashe, S. K.;
- Rasmussen, R. A.;
- Watkins, J. D.;
- Vyas, H. K.;
- Mukhtar, M. M.;
- Hemashettar, G.;
- Thorat, S.;
- J.K. Yoon;
- Villinger, F.;
- Novembre, F. J.;
- Landucci, G.;
- Forthal, D. N.;
- Ratcliffe, S.;
- Robert-Guroff, M.;
- Polonis, V.;
- Montefiori, D. C.;
- Ertl, H. C.
Publication type:
Abstract
Soluble and bacteriophage T4 displayed gp41 mutant proteins as HIV-1 vaccine candidates.
Published in:
2012
By:
- Gao, G.;
- Peachman, K. K.;
- Wieczorek, L.;
- Polonis, V.;
- Alving, C. R.;
- Rao, M.;
- Rao, V. B.
Publication type:
Abstract
Cross-clade neutralization of HIV-1 by a monoclonal antibody obtained by immunization with liposomes containing lipid A and a synthetic MPER peptide.
Published in:
2012
By:
- Matyas, G. R.;
- Jobe, O.;
- Wieczorek, L.;
- Peachman, K. K.;
- Beck, Z.;
- Polonis, V. R.;
- Rao, M.;
- Alving, C. R.
Publication type:
Abstract
Antibody-mediated inhibition of HIV-1 elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults.
Published in:
2012
By:
- Joachim, A.;
- Nilsson, C.;
- Aboud, S.;
- Lyamuya, E. F.;
- Robb, M.;
- Marovich, M.;
- Ochsenbauer, C.;
- Wahren, B.;
- Sandström, E.;
- Biberfeld, G.;
- Ferrari, G.;
- Polonis, V. R.
Publication type:
Abstract
Safety and immunogenicity of a randomized phase I prime-boost trial with ALVAC-HIV (vCP205) and gp160 MN/LAI-2 adjuvanted in alum or polyphosphazene.
Published in:
2012
By:
- O'Connell, R. J.;
- Polonis, V. R.;
- Ratto-Kim, S.;
- Cox, J.;
- Jagodzinski, L. L.;
- Malia, J.;
- Michael, N. L.;
- Excler, J.;
- Robb, M. L.;
- J. H. Kim
Publication type:
Abstract

Found: 9